坦索罗辛联合通癃启闭汤治疗前列腺增生患者的临床疗效

Tamsulosin and Tonglong Kai Clinical Closed Decoction in the Treatment of Benign Prostatic Hyperplasia

目的探讨坦索罗辛联合通癃启闭汤治疗前列腺增生(BPH)患者的临床疗效。方法选取2014年2月至2015年2月阜新市中医院收治的BPH患者148例为研究对象,按随机数字表法分为对照组和观察组,各74例。对照组患者口服坦索罗辛,观察组患者在对照组基础上服用通癃启闭汤,比较两组患者治疗前后的国际前列腺症状(IPSS)评分、症状性BPH剩余尿(PVR)、最大尿流率(Qmax)以及临床疗效。结果观察组患者的总有效率为94.6%,明显高于对照组的82.4%,差异有统计学意义(P<0.05);观察组患者的IPSS评分明显低于对照组,PRV明显少于对照组,Qmax明显大于对照组,差异均有统计学意义(均P<0.05)。结论坦索罗辛联合通癃启闭汤治疗BPH患者,能明显改善其临床症状,疗效甚佳。

Objective To investigate the joint through infirmity hoist soup tamsulosin for benign prostatic hyperplasia（BPH）in patients with clinical efficacy.Methods From February 2014 to February 2015,148 patients with BPH were randomly divided into control group and research group,74 cases in each group.The control group was treated with tamsulosin,study group of patients in the control group based on taking tonglong opening and closing decoction,compared two groups of patients before and after treatment the international prostate symptoms（IPSS） score,symptoms of benign prostatic hyperplasia（BPH）,residual urine（PVR）,maximal urinary flow rate（Qmax） and clinical curative effect.Results The total effective rate of the study group was 82.4%,significantly higher than the control group,the difference was statistically significant（P〈0.05）;after treatment,the IPSS score of the study group was significantly lower than that of the control group,Qmax was significantly higher than the control group,the difference was statistically significant（P〈0.05）.Conclusion Tamsulosin and tonglong Qibi Decoction in the treatment of BPH can significantly improve the clinical symptoms,the curative effect is very good.